Awareness of and Preferences for Preexposure Prophylaxis (PrEP) among MSM at High Risk of HIV Infection in Southern China: Findings from the T2T Study
Table 2
Awareness, willingness, and preferences for oral and long-acting injectable HIV preexposure prophylaxis (PrEP) among MSM in southern China ().
Variables
Response categories
Frequency
Percentage (%)
Heard of PrEP
No
313
56.9
Yes
237
43.1
Willingness to use PrEP
No
188
34.2
Yes
362
65.8
Willingness to use daily oral PrEP
No
208
37.8
Yes
342
62.2
Willingness to use LAI-PrEP
No
338
61.5
Yes
212
38.5
Reasons for willingness to use PrEPa
At high risk of HIV infection
66
18.2
Partner/s at high risk of HIV infection
36
9.9
To reduce risk
307
84.8
Other reasonsb
16
4.4
Reasons for unwillingness to use PrEPa
Too expensive
79
41.0
At low risk of HIV infection
43
22.3
Concerns about drug resistance
32
16.5
Trypanophobia
14
7.4
Concerns about side-effects
82
43.1
Poor medication adherence
45
23.4
Other reasonsc
37
19.7
Adaptable frequency of using oral PrEPd
Non-daily
161
47.1
Daily
181
52.9
Adaptable frequency of using LAI-PrEPd
Once every 3 or more months
75
35.4
Once every 2 months
32
15.1
Once a month
105
49.5
LAI: long-acting injectable; PrEP: preexposure prophylaxis. aMultiple-choice question. The number of participants who were willing to use PrEP was 362, and the opposite was 188. bOther reasons included curiosity and recommendation from friends. cOther reasons included job, family, and ease of suspicion. dThe number of participants who were willing to use oral PrEP was 342, and the number of participants who were willing to use LAI-PrEP was 212.